Skip to content
PsychoGenics Transforming CNS discovery
Solutions
Therapeutic Areas
Sleep & Seizure Disorders
Mental Illnesses
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain Disorders
Rare CNS Disorders
Traumatic Brain Injury & Spinal Cord Injury
Preclinical CNS Services
Behavioral and
In Vivo
Testing
Drug Abuse Liability
EEG Studies
Electrophysiology
Preclinical
Ex Vivo
Sample Biomarker Analysis Services
Immunohistochemistry (IHC) & Histology Services
Microdialysis
Pharmacokinetic & Pharmacodynamic (PK/PD) Services
Receptor Occupancy
In Vivo
AI Platforms
eCube™
NeuroCube®
PhenoCube®
SmartCube®
Emerging Therapies
Cell and Gene Therapies
Microbiome
Psychedelics
About
Our Team
Careers
Culture
News
Events
Our Research
Disease Foundations
Contact Us
Open Search
Search
Solutions
Therapeutic Areas
Sleep & Seizure Disorders
Mental Illnesses
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain Disorders
Rare CNS Disorders
Traumatic Brain Injury & Spinal Cord Injury
Preclinical CNS Services
Behavioral and
In Vivo
Testing
Drug Abuse Liability
EEG Studies
Electrophysiology
Preclinical
Ex Vivo
Sample Biomarker Analysis Services
Immunohistochemistry (IHC) & Histology Services
Microdialysis
Pharmacokinetic & Pharmacodynamic (PK/PD) Services
Receptor Occupancy
In Vivo
AI Platforms
eCube™
NeuroCube®
PhenoCube®
SmartCube®
Emerging Therapies
Cell and Gene Therapies
Microbiome
Psychedelics
About
Our Team
Careers
Culture
News
Events
Our Research
Disease Foundations
Contact Us
Close Menu
Publication
Resources
Overcoming mental health’s drug development challenges with AI
Resources
PsychoGenics – Phenotypic Drug Discovery and Preclinical CRO
Resources
We need a new Prozac: The demand for new brain drug innovation
Resources
Mental Health Champions: Why & How Dr. Emer Leahy of PsychoGenics Is Helping To Champion Mental Wellness
Resources
The CNS drug development drum beat is getting louder
Resources
Emyria starts program with neuroscience drug discovery CRO
Resources
Clinical Catch-Up
Resources
Emyria teams with CRO PsychoGenics for MDMA-like drug development
Resources
Why Psychogenics and Emyria are collaborating to examine MDMA-inspired compounds
Resources
New partnership may give MDMA an edge in the psychedelics space
Posts navigation
1
2
…
16
Next
Partner with us and transform your program
DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS
Get Started